Biosimilars and Interchangeable Biologics - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Biosimilars and Interchangeable Biologics write by Sarfaraz K. Niazi. This book was released on 2018-10-30. Biosimilars and Interchangeable Biologics available in PDF, EPUB and Kindle. What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.
Biosimilar and Interchangeable Biologics
Biosimilar and Interchangeable Biologics - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Biosimilar and Interchangeable Biologics write by Sarfaraz K. Niazi. This book was released on 2016-02-15. Biosimilar and Interchangeable Biologics available in PDF, EPUB and Kindle. The field of biosimilar drugs is one of the hottest subjects in the filed of new drug development, with scores of companies offering seminar and training programs for prospective manufacturers and stakeholders. This book is a modern comprehensive overview of the entire biosimilar manufacturing and distribution process, covering concepts introduced by the FDA, litigation strategies, analytical methods, pharmokinetic studies, and the future and current status of biosimilar product approvals.
Biosimilars and Interchangeable Biologics
Biosimilars and Interchangeable Biologics - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Biosimilars and Interchangeable Biologics write by Sarfaraz K. Niazi. This book was released on 2018-10-30. Biosimilars and Interchangeable Biologics available in PDF, EPUB and Kindle. What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.
Biosimilars and Interchangeable Biologics
Biosimilars and Interchangeable Biologics - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Biosimilars and Interchangeable Biologics write by Sarfaraz K. Niazi. This book was released on 2016-01-05. Biosimilars and Interchangeable Biologics available in PDF, EPUB and Kindle. What's the Deal with Biosimilars?Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set th
Biologics, Biosimilars, and Biobetters
Biologics, Biosimilars, and Biobetters - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Biologics, Biosimilars, and Biobetters write by Iqbal Ramzan. This book was released on 2021-02-03. Biologics, Biosimilars, and Biobetters available in PDF, EPUB and Kindle. A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists
